EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category  |
Confidence Level |
|---|
   3.4.22.26 | Carcinoma |
1310878 |
Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patients. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
1
0 |
| 3.4.22.26 | Carcinoma |
3530904 |
gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 3.4.22.26 | Carcinoma |
7016982 |
A proteolytic procoagulant associated with malignant transformation. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
3
4
1 |
| 3.4.22.26 | Neoplasms |
9639510 |
Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. |
causal interaction
ongoing research
unassigned |
3
3
0 |
| 3.4.22.26 | Neoplasms |
11990487 |
Biochemistry of cancer procoagulant. |
causal interaction
unassigned |
3
0 |
| 3.4.22.26 | Neoplasms |
15246868 |
Properties of proteins in cancer procoagulant preparations that are detected by anti-tissue factor antibodies. |
causal interaction
unassigned |
1
0 |
| 3.4.22.26 | Neoplasms |
15600294 |
[Cancer procoagulant activity in serum and neoplastic tissue in cases of cervical and uterine carcinoma] |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
4
3
0 |
| 3.4.22.26 | Neoplasms |
15837545 |
Effect of cancer procoagulant (CP) on the growth and adhesion of MCF-7 cells to vitronectin in vitro. |
causal interaction
ongoing research
unassigned |
4
4
0 |
| 3.4.22.26 | Neoplasms |
16122189 |
The activity of cancer procoagulant in cases of uterine leiomyomas. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
2
1
0 |
| 3.4.22.26 | Neoplasms |
16171148 |
[Cancer procoagulant (CP)] |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
2
2
2 |
